GlassScriptPhysician profile
Marisa Cueva
NPI 1053771097
$2,946.91
in general payments reported to CMS, 2019-2025
29 companies · $583 in 2025
The $583 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $497 · 2022: $889 · 2023: $549 · 2024: $428 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.78 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $406.46 | 2022-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $394.74 | 2022-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $236.58 | 2024-2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $225.92 | 2021-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.83 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $205.76 | 2021-2024 | Xarelto |
| Esperion Therapeutics, INC. | $204.80 | 2021-2023 | Nexletol |
| Boston Scientific Corporation | $152.73 | 2022-2024 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.37 | 2021-2023 | Jardiance |
| Abbott Laboratories | $142.68 | 2021-2025 | Cardiomems |
| Kestra Medical Technology Services, INC. | $96.81 | 2025 | Assure Wcd |
| Atricure, INC. | $83.32 | 2022 | |
| Novartis Pharmaceuticals Corporation | $75.54 | 2023-2025 | |
| Baxter Healthcare | $41.60 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Tactile Systems Technology INC | $40.25 | 2022-2023 | Flexitouch Plus, Entre Plus |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $39.04 | 2021-2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $27.13 | 2022 | |
| Cvrx, INC. | $25.98 | 2023 | Barostim Neo System |
| Scpharmaceuticals INC. | $24.23 | 2025 | |
| Siemens Medical Solutions USA, INC. | $21.96 | 2022 | |
| Glaxosmithkline, LLC. | $21.48 | 2025 | Arexvy, Shingrix |
| Cleerly, INC. | $18.98 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Azurity Pharmaceuticals, INC. | $18.85 | 2023 | Edarbi |
| Arbor Pharmaceuticals, INC. | $18.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $18.79 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $14.86 | 2024 | |
| Pfizer INC. | $13.18 | 2022 | |
| Cashflow Solutions, LLC | $13.13 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Biotronik INC. | $13.07 | 2023 | Orsiro Mission |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Cueva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.